Independence Blue Cross offers broad array of Medicare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Independence Blue Cross offers broad array of Medicare choices with lower premiums

PHILADELPHIA, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Independence Blue Cross (IBC) today announced that for 2014 it will continue to offer its Keystone 65 Select HMO Medicare Advantage (MA) plan with no monthly premium in all five counties it serves. The Select plan is one of eight comprehensive IBC options Medicare beneficiaries can choose during this year's annual enrollment period from October 15 to December 7, with benefits effective January 1, 2014.

IBC is also pleased to announce that for 2014:

  • Most of its Medicare Advantage plan premiums will decrease .
  • Personal Choice 65 PPO premiums will decrease by nearly 41 percent for the medical only product and by nearly 23 percent for medical and prescription drug product in Bucks and Philadelphia counties.
  • IBC's zero premium Keystone 65 Select Rx HMO plan will also include prescription drug at no additional cost in Bucks and Philadelphia counties with reduced premiums for this product and prescription drug in Delaware, Chester, and Montgomery counties.  
  • There will be no change in premium to the Keystone 65 Preferred HMO medical only product and minimal increases averaging between 1.4 and 6.3 percent to include prescription drug coverage. 
  • Keystone Select 65 HMO plan provides members access to a robust network of hospitals, which includes most of the region's top hospitals. A list of participating hospitals is available at www.ibxmedicare.com .

"Our 2014 Medicare products continue to offer the long-term stability and peace of mind our members have come to expect from Independence Blue Cross," said Robert J. Smith, IBC vice president of sales and marketing for government markets. "As the largest Medicare health plan in our region, we've worked hard to be the plan people know and trust by staying committed to our members over the years while other insurers have come and gone.  We are excited to offer a variety of affordable plans to fit every member's needs."

IBC's full portfolio of Medicare health plans in 2014 includes four Keystone 65 Select HMO options, two Keystone 65 Preferred HMO plans, and two Personal Choice 65 PPO plan options in addition to prescription drug and Medicare Supplement products.

All of IBC's Medicare Advantage plans offer members additional value by including extra benefits to help keep its members healthy, such as the SilverSneakers® fitness program, at no cost. IBC's Medicare Advantage health plans also include coverage for emergency or urgent care anywhere in the world—providing members the security they need when on the go.  In addition, IBC's health plans offer hearing, dental, and vision coverage, which is included in the monthly premium for some plans and can be purchased for $7 a month for other plans.

IBC also offers BlueExtra SM , a low-cost supplemental plan that includes dental, vision, and hearing aid coverage — benefits that are often not included in Medicare Advantage or Medicare Supplement plans. BlueExtra may be purchased by anyone who would like to have hearing, dental, or vision coverage in addition to their medical coverage, whether or not they are covered by an IBC health plan.

"We are committed to serving our members and prospective members during this open enrollment period and speaking with them about ways to save them money and keep them healthy," said Smith. "We have more than 1,000 dedicated licensed brokers/sales agents available to help members make the best plan choice to meet their needs. We're hosting more than 200 meetings and setting up information booths at a number of local retail pharmacies and supermarkets throughout the five counties to help people get the information they need to make informed decisions."

Enrollment rules and options

The Centers for Medicare and Medicaid Services (CMS) generally permits individual Medicare beneficiaries to enroll in a Medicare Advantage plan or Part D plan only during the six-week annual enrollment period, from October 15 to December 7. Beneficiaries cannot change to another Medicare Advantage plan after December 7, however, from January 1 to February 14, CMS allows Medicare beneficiaries to disenroll from a MA plan and sign up for a Medicare Supplement or return to Original Medicare.

Members and prospective members can learn more about IBC's Medicare plans by visiting www.ibxmedicare.com or calling 1-877-393-6733 or TTY/TDD: 1-877-219-5457 and signing up for an IBC information meeting held at locations across southeastern Pennsylvania from now until year-end. In addition, beneficiaries can buy an IBC individual MA plan through one of IBC's licensed brokers or agents.

About Independence Blue Cross

Proudly celebrating its 75th anniversary in 2013, Independence Blue Cross is the leading health insurer in southeastern Pennsylvania. With our affiliates, we serve more than 7 million people nationwide, including 2.2 million in the region. We are enhancing the health and wellness of the people and communities we serve by delivering innovative and competitively priced health care products and services; pioneering new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and supporting programs and events that promote wellness. To learn more about how we're changing the game, visit www.ibx.com . Connect with us on Facebook at ibx.com/facebook and on Twitter at @ibx. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.

Media contacts: Karen Godlewski 215-2421-3113 Cell: 215-779-9682 Ruth Stoolman 215-241- 24807 Cell: 215-667-9537

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 26

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Crypto Developments: Circle's Blockchain, Ethereum Bets, and More

Updated Category News Views 251

The Current Landscape of Cryptocurrency The last week in the world of cryptocurrency and finance has been nothing less than exhilarating. With significant developments, including the launch of a new blockchain by Circle Internet Group Inc. and major investments in Ethereum, there is plenty to discuss. Let’s explore the most noteworthy stories that are shaping the crypto...

Continue Reading
ezPaycheck 2025 Payroll Software: Cost-Effective Compliance Solution

Updated Category News Views 132

ezPaycheck 2025: The Efficient Payroll Solution The new ezPaycheck 2025 payroll software is now available, offering businesses an excellent in-house solution for payroll processing that is both compliant and economical. This updated version comes with essential features designed to make payroll management easier than ever. Priced at just $169 for a single installation,...

Continue Reading
Investors of Applied Therapeutics, Inc. Should Take Action Now

Updated Category News Views 188

Understanding the Securities Fraud Allegations Against Applied Therapeutics Applied Therapeutics, Inc. (APLT) has found itself at the heart of a securities fraud class action lawsuit. This legal proceeding has been announced by The Law Offices of Frank R. Cruz as they represent investors who acquired shares during a significant time frame. The legal challenge highlights...

Continue Reading
Ardagh Metal Packaging Reports Positive Year-End 2024 Results

Updated Category News Views 148

Ardagh Metal Packaging's Year-End 2024 Results Ardagh Metal Packaging S.A. (NYSE: AMBP) recently reported their impressive results for the full year and fourth quarter of 2024. The company's performance is a reflection of strategic growth and resilience in a challenging market environment. Quarterly and Annual Performance Overview For the fourth quarter of 2024, Ardagh...

Continue Reading
Empowering Voices: The Call to Protect Our Children

Updated Category News Views 243

Making a Stand Against Child Trafficking In a heartfelt initiative, ThinkCareBelieve has announced a powerful call to action aimed at ensuring the safety and protection of children across the nation. This initiative addresses the urgent concern of child trafficking and the plight of missing children, many of whom have been smuggled through borders and placed in unsafe...

Continue Reading